nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Chills—Temozolomide—melanoma	0.000832	0.00106	CcSEcCtD
Gabapentin—Dehydration—Docetaxel—melanoma	0.000829	0.00106	CcSEcCtD
Gabapentin—Ill-defined disorder—Dactinomycin—melanoma	0.000828	0.00106	CcSEcCtD
Gabapentin—Anaemia—Dactinomycin—melanoma	0.000825	0.00105	CcSEcCtD
Gabapentin—Liver function test abnormal—Docetaxel—melanoma	0.000823	0.00105	CcSEcCtD
Gabapentin—Vomiting—Vemurafenib—melanoma	0.00082	0.00105	CcSEcCtD
Gabapentin—Alopecia—Temozolomide—melanoma	0.000819	0.00104	CcSEcCtD
Gabapentin—Dry skin—Docetaxel—melanoma	0.000817	0.00104	CcSEcCtD
Gabapentin—Chest pain—Bleomycin—melanoma	0.000815	0.00104	CcSEcCtD
Gabapentin—Myalgia—Bleomycin—melanoma	0.000815	0.00104	CcSEcCtD
Gabapentin—Rash—Vemurafenib—melanoma	0.000813	0.00104	CcSEcCtD
Gabapentin—Mental disorder—Temozolomide—melanoma	0.000812	0.00104	CcSEcCtD
Gabapentin—Dermatitis—Vemurafenib—melanoma	0.000812	0.00104	CcSEcCtD
Gabapentin—Back pain—Carmustine—melanoma	0.000808	0.00103	CcSEcCtD
Gabapentin—Headache—Vemurafenib—melanoma	0.000808	0.00103	CcSEcCtD
Gabapentin—Malnutrition—Temozolomide—melanoma	0.000807	0.00103	CcSEcCtD
Gabapentin—Erythema—Temozolomide—melanoma	0.000807	0.00103	CcSEcCtD
Gabapentin—Breast disorder—Docetaxel—melanoma	0.000806	0.00103	CcSEcCtD
Gabapentin—Discomfort—Bleomycin—melanoma	0.000805	0.00103	CcSEcCtD
Gabapentin—Malaise—Dactinomycin—melanoma	0.000805	0.00103	CcSEcCtD
Gabapentin—Leukopenia—Dactinomycin—melanoma	0.000799	0.00102	CcSEcCtD
Gabapentin—Nasopharyngitis—Docetaxel—melanoma	0.000797	0.00102	CcSEcCtD
Gabapentin—Dysgeusia—Temozolomide—melanoma	0.000791	0.00101	CcSEcCtD
Gabapentin—Confusional state—Bleomycin—melanoma	0.000788	0.001	CcSEcCtD
Gabapentin—Vision blurred—Carmustine—melanoma	0.000787	0.001	CcSEcCtD
Gabapentin—Tremor—Carmustine—melanoma	0.000783	0.000998	CcSEcCtD
Gabapentin—Anaphylactic shock—Bleomycin—melanoma	0.000781	0.000996	CcSEcCtD
Gabapentin—Oedema—Bleomycin—melanoma	0.000781	0.000996	CcSEcCtD
Gabapentin—Back pain—Temozolomide—melanoma	0.000781	0.000996	CcSEcCtD
Gabapentin—Infection—Bleomycin—melanoma	0.000776	0.000989	CcSEcCtD
Gabapentin—Anaemia—Carmustine—melanoma	0.000772	0.000985	CcSEcCtD
Gabapentin—Dysphagia—Docetaxel—melanoma	0.00077	0.000983	CcSEcCtD
Gabapentin—Agitation—Carmustine—melanoma	0.000768	0.000979	CcSEcCtD
Gabapentin—Nausea—Vemurafenib—melanoma	0.000766	0.000976	CcSEcCtD
Gabapentin—Thrombocytopenia—Bleomycin—melanoma	0.000765	0.000975	CcSEcCtD
Gabapentin—Vision blurred—Temozolomide—melanoma	0.000761	0.00097	CcSEcCtD
Gabapentin—Myalgia—Dactinomycin—melanoma	0.00076	0.000969	CcSEcCtD
Gabapentin—Bronchospasm—Docetaxel—melanoma	0.000758	0.000966	CcSEcCtD
Gabapentin—Tremor—Temozolomide—melanoma	0.000756	0.000964	CcSEcCtD
Gabapentin—Discomfort—Dactinomycin—melanoma	0.000751	0.000957	CcSEcCtD
Gabapentin—Angina pectoris—Docetaxel—melanoma	0.000751	0.000957	CcSEcCtD
Gabapentin—Ill-defined disorder—Temozolomide—melanoma	0.000749	0.000955	CcSEcCtD
Gabapentin—Leukopenia—Carmustine—melanoma	0.000748	0.000954	CcSEcCtD
Gabapentin—Anaemia—Temozolomide—melanoma	0.000746	0.000951	CcSEcCtD
Gabapentin—Anorexia—Bleomycin—melanoma	0.000745	0.000949	CcSEcCtD
Gabapentin—Agitation—Temozolomide—melanoma	0.000742	0.000946	CcSEcCtD
Gabapentin—Angioedema—Temozolomide—melanoma	0.000738	0.000941	CcSEcCtD
Gabapentin—Hypotension—Bleomycin—melanoma	0.00073	0.000931	CcSEcCtD
Gabapentin—Oedema—Dactinomycin—melanoma	0.000728	0.000929	CcSEcCtD
Gabapentin—Malaise—Temozolomide—melanoma	0.000728	0.000928	CcSEcCtD
Gabapentin—Vertigo—Temozolomide—melanoma	0.000725	0.000925	CcSEcCtD
Gabapentin—Convulsion—Carmustine—melanoma	0.000724	0.000923	CcSEcCtD
Gabapentin—Infection—Dactinomycin—melanoma	0.000724	0.000923	CcSEcCtD
Gabapentin—Leukopenia—Temozolomide—melanoma	0.000723	0.000921	CcSEcCtD
Gabapentin—Hypertension—Carmustine—melanoma	0.000721	0.00092	CcSEcCtD
Gabapentin—Palpitations—Temozolomide—melanoma	0.000713	0.00091	CcSEcCtD
Gabapentin—Thrombocytopenia—Dactinomycin—melanoma	0.000713	0.000909	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000712	0.000907	CcSEcCtD
Gabapentin—Myalgia—Carmustine—melanoma	0.000711	0.000907	CcSEcCtD
Gabapentin—Chest pain—Carmustine—melanoma	0.000711	0.000907	CcSEcCtD
Gabapentin—Anxiety—Carmustine—melanoma	0.000709	0.000904	CcSEcCtD
Gabapentin—Cough—Temozolomide—melanoma	0.000704	0.000898	CcSEcCtD
Gabapentin—Paraesthesia—Bleomycin—melanoma	0.000701	0.000894	CcSEcCtD
Gabapentin—Weight increased—Docetaxel—melanoma	0.000701	0.000894	CcSEcCtD
Gabapentin—Convulsion—Temozolomide—melanoma	0.000699	0.000892	CcSEcCtD
Gabapentin—Weight decreased—Docetaxel—melanoma	0.000697	0.000889	CcSEcCtD
Gabapentin—Hypertension—Temozolomide—melanoma	0.000697	0.000889	CcSEcCtD
Gabapentin—Dyspnoea—Bleomycin—melanoma	0.000696	0.000888	CcSEcCtD
Gabapentin—Anorexia—Dactinomycin—melanoma	0.000694	0.000885	CcSEcCtD
Gabapentin—Pneumonia—Docetaxel—melanoma	0.000691	0.000881	CcSEcCtD
Gabapentin—Confusional state—Carmustine—melanoma	0.000687	0.000877	CcSEcCtD
Gabapentin—Arthralgia—Temozolomide—melanoma	0.000687	0.000876	CcSEcCtD
Gabapentin—Myalgia—Temozolomide—melanoma	0.000687	0.000876	CcSEcCtD
Gabapentin—Infestation NOS—Docetaxel—melanoma	0.000687	0.000876	CcSEcCtD
Gabapentin—Infestation—Docetaxel—melanoma	0.000687	0.000876	CcSEcCtD
Gabapentin—Anxiety—Temozolomide—melanoma	0.000685	0.000873	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000683	0.00087	CcSEcCtD
Gabapentin—Oedema—Carmustine—melanoma	0.000682	0.000869	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000681	0.000869	CcSEcCtD
Gabapentin—Discomfort—Temozolomide—melanoma	0.000679	0.000866	CcSEcCtD
Gabapentin—Decreased appetite—Bleomycin—melanoma	0.000679	0.000866	CcSEcCtD
Gabapentin—Infection—Carmustine—melanoma	0.000677	0.000864	CcSEcCtD
Gabapentin—Acute coronary syndrome—Docetaxel—melanoma	0.000677	0.000864	CcSEcCtD
Gabapentin—Renal failure—Docetaxel—melanoma	0.000675	0.000861	CcSEcCtD
Gabapentin—Neuropathy peripheral—Docetaxel—melanoma	0.000673	0.000859	CcSEcCtD
Gabapentin—Myocardial infarction—Docetaxel—melanoma	0.000673	0.000859	CcSEcCtD
Gabapentin—Dry mouth—Temozolomide—melanoma	0.000672	0.000857	CcSEcCtD
Gabapentin—Stomatitis—Docetaxel—melanoma	0.00067	0.000854	CcSEcCtD
Gabapentin—Jaundice—Docetaxel—melanoma	0.00067	0.000854	CcSEcCtD
Gabapentin—Pain—Bleomycin—melanoma	0.000668	0.000852	CcSEcCtD
Gabapentin—Conjunctivitis—Docetaxel—melanoma	0.000668	0.000852	CcSEcCtD
Gabapentin—Thrombocytopenia—Carmustine—melanoma	0.000668	0.000851	CcSEcCtD
Gabapentin—Tachycardia—Carmustine—melanoma	0.000665	0.000849	CcSEcCtD
Gabapentin—Confusional state—Temozolomide—melanoma	0.000664	0.000847	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000664	0.000846	CcSEcCtD
Gabapentin—Anaphylactic shock—Temozolomide—melanoma	0.000659	0.00084	CcSEcCtD
Gabapentin—Oedema—Temozolomide—melanoma	0.000659	0.00084	CcSEcCtD
Gabapentin—Infection—Temozolomide—melanoma	0.000655	0.000835	CcSEcCtD
Gabapentin—Anorexia—Carmustine—melanoma	0.00065	0.000829	CcSEcCtD
Gabapentin—Hepatobiliary disease—Docetaxel—melanoma	0.00065	0.000829	CcSEcCtD
Gabapentin—Epistaxis—Docetaxel—melanoma	0.000648	0.000826	CcSEcCtD
Gabapentin—Nervous system disorder—Temozolomide—melanoma	0.000646	0.000824	CcSEcCtD
Gabapentin—Thrombocytopenia—Temozolomide—melanoma	0.000645	0.000823	CcSEcCtD
Gabapentin—Feeling abnormal—Bleomycin—melanoma	0.000644	0.000821	CcSEcCtD
Gabapentin—Skin disorder—Temozolomide—melanoma	0.00064	0.000816	CcSEcCtD
Gabapentin—Hypotension—Carmustine—melanoma	0.000637	0.000812	CcSEcCtD
Gabapentin—Hyperhidrosis—Temozolomide—melanoma	0.000637	0.000812	CcSEcCtD
Gabapentin—Decreased appetite—Dactinomycin—melanoma	0.000633	0.000807	CcSEcCtD
Gabapentin—Fatigue—Dactinomycin—melanoma	0.000628	0.000801	CcSEcCtD
Gabapentin—Anorexia—Temozolomide—melanoma	0.000628	0.000801	CcSEcCtD
Gabapentin—Pain—Dactinomycin—melanoma	0.000623	0.000794	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Carmustine—melanoma	0.000621	0.000792	CcSEcCtD
Gabapentin—Urticaria—Bleomycin—melanoma	0.00062	0.000791	CcSEcCtD
Gabapentin—Rhinitis—Docetaxel—melanoma	0.000618	0.000788	CcSEcCtD
Gabapentin—Body temperature increased—Bleomycin—melanoma	0.000617	0.000787	CcSEcCtD
Gabapentin—Haemorrhage—Docetaxel—melanoma	0.000617	0.000786	CcSEcCtD
Gabapentin—Hepatitis—Docetaxel—melanoma	0.000617	0.000786	CcSEcCtD
Gabapentin—Insomnia—Carmustine—melanoma	0.000617	0.000786	CcSEcCtD
Gabapentin—Hypoaesthesia—Docetaxel—melanoma	0.000614	0.000782	CcSEcCtD
Gabapentin—Paraesthesia—Carmustine—melanoma	0.000612	0.000781	CcSEcCtD
Gabapentin—Pharyngitis—Docetaxel—melanoma	0.000612	0.000781	CcSEcCtD
Gabapentin—Urinary tract disorder—Docetaxel—melanoma	0.000609	0.000777	CcSEcCtD
Gabapentin—Dyspnoea—Carmustine—melanoma	0.000608	0.000775	CcSEcCtD
Gabapentin—Oedema peripheral—Docetaxel—melanoma	0.000608	0.000775	CcSEcCtD
Gabapentin—Somnolence—Carmustine—melanoma	0.000606	0.000773	CcSEcCtD
Gabapentin—Connective tissue disorder—Docetaxel—melanoma	0.000606	0.000773	CcSEcCtD
Gabapentin—Urethral disorder—Docetaxel—melanoma	0.000605	0.000771	CcSEcCtD
Gabapentin—Feeling abnormal—Dactinomycin—melanoma	0.0006	0.000765	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Temozolomide—melanoma	0.0006	0.000765	CcSEcCtD
Gabapentin—Insomnia—Temozolomide—melanoma	0.000596	0.00076	CcSEcCtD
Gabapentin—Gastrointestinal pain—Dactinomycin—melanoma	0.000596	0.00076	CcSEcCtD
Gabapentin—Visual impairment—Docetaxel—melanoma	0.000594	0.000758	CcSEcCtD
Gabapentin—Decreased appetite—Carmustine—melanoma	0.000593	0.000756	CcSEcCtD
Gabapentin—Paraesthesia—Temozolomide—melanoma	0.000592	0.000754	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Carmustine—melanoma	0.000589	0.000751	CcSEcCtD
Gabapentin—Dyspnoea—Temozolomide—melanoma	0.000587	0.000749	CcSEcCtD
Gabapentin—Somnolence—Temozolomide—melanoma	0.000586	0.000747	CcSEcCtD
Gabapentin—Erythema multiforme—Docetaxel—melanoma	0.000583	0.000744	CcSEcCtD
Gabapentin—Constipation—Carmustine—melanoma	0.000583	0.000743	CcSEcCtD
Gabapentin—Pain—Carmustine—melanoma	0.000583	0.000743	CcSEcCtD
Gabapentin—Dyspepsia—Temozolomide—melanoma	0.00058	0.00074	CcSEcCtD
Gabapentin—Eye disorder—Docetaxel—melanoma	0.000576	0.000735	CcSEcCtD
Gabapentin—Abdominal pain—Dactinomycin—melanoma	0.000576	0.000734	CcSEcCtD
Gabapentin—Body temperature increased—Dactinomycin—melanoma	0.000576	0.000734	CcSEcCtD
Gabapentin—Hypersensitivity—Bleomycin—melanoma	0.000575	0.000734	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—PRKCA—melanoma	0.000575	0.00267	CbGpPWpGaD
Gabapentin—Decreased appetite—Temozolomide—melanoma	0.000573	0.00073	CcSEcCtD
Gabapentin—Cardiac disorder—Docetaxel—melanoma	0.000572	0.00073	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Temozolomide—melanoma	0.000569	0.000725	CcSEcCtD
Gabapentin—Fatigue—Temozolomide—melanoma	0.000568	0.000724	CcSEcCtD
Gabapentin—Pain—Temozolomide—melanoma	0.000563	0.000718	CcSEcCtD
Gabapentin—Constipation—Temozolomide—melanoma	0.000563	0.000718	CcSEcCtD
Gabapentin—Feeling abnormal—Carmustine—melanoma	0.000562	0.000716	CcSEcCtD
Gabapentin—Asthenia—Bleomycin—melanoma	0.00056	0.000715	CcSEcCtD
Gabapentin—Gastrointestinal pain—Carmustine—melanoma	0.000558	0.000711	CcSEcCtD
Gabapentin—Immune system disorder—Docetaxel—melanoma	0.000557	0.00071	CcSEcCtD
Gabapentin—Mediastinal disorder—Docetaxel—melanoma	0.000556	0.000709	CcSEcCtD
Gabapentin—Chills—Docetaxel—melanoma	0.000553	0.000706	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BRAF—melanoma	0.000553	0.00256	CbGpPWpGaD
Gabapentin—Pruritus—Bleomycin—melanoma	0.000553	0.000705	CcSEcCtD
Gabapentin—Alopecia—Docetaxel—melanoma	0.000545	0.000695	CcSEcCtD
Gabapentin—Feeling abnormal—Temozolomide—melanoma	0.000543	0.000692	CcSEcCtD
Gabapentin—Mental disorder—Docetaxel—melanoma	0.00054	0.000689	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CXCR2—melanoma	0.00054	0.0025	CbGpPWpGaD
Gabapentin—Abdominal pain—Carmustine—melanoma	0.000539	0.000687	CcSEcCtD
Gabapentin—Body temperature increased—Carmustine—melanoma	0.000539	0.000687	CcSEcCtD
Gabapentin—Gastrointestinal pain—Temozolomide—melanoma	0.000539	0.000687	CcSEcCtD
Gabapentin—Erythema—Docetaxel—melanoma	0.000537	0.000685	CcSEcCtD
Gabapentin—Malnutrition—Docetaxel—melanoma	0.000537	0.000685	CcSEcCtD
Gabapentin—Hypersensitivity—Dactinomycin—melanoma	0.000537	0.000684	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—MDM2—melanoma	0.000536	0.00248	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PLCB4—melanoma	0.000531	0.00246	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL1—melanoma	0.000531	0.00246	CbGpPWpGaD
Gabapentin—Dysgeusia—Docetaxel—melanoma	0.000526	0.00067	CcSEcCtD
Gabapentin—Urticaria—Temozolomide—melanoma	0.000523	0.000667	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—WNT5A—melanoma	0.000523	0.00242	CbGpPWpGaD
Gabapentin—Asthenia—Dactinomycin—melanoma	0.000523	0.000666	CcSEcCtD
Gabapentin—Abdominal pain—Temozolomide—melanoma	0.000521	0.000664	CcSEcCtD
Gabapentin—Body temperature increased—Temozolomide—melanoma	0.000521	0.000664	CcSEcCtD
Gabapentin—Back pain—Docetaxel—melanoma	0.000519	0.000662	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—melanoma	0.000518	0.0024	CbGpPWpGaD
Gabapentin—Muscle spasms—Docetaxel—melanoma	0.000516	0.000658	CcSEcCtD
Gabapentin—Hypersensitivity—Carmustine—melanoma	0.000502	0.000641	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—FAS—melanoma	0.000502	0.00233	CbGpPWpGaD
Gabapentin—Diarrhoea—Dactinomycin—melanoma	0.000498	0.000636	CcSEcCtD
Gabapentin—Vomiting—Bleomycin—melanoma	0.000497	0.000633	CcSEcCtD
Gabapentin—Anaemia—Docetaxel—melanoma	0.000496	0.000633	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PLA2G6—melanoma	0.000495	0.00229	CbGpPWpGaD
Gabapentin—Rash—Bleomycin—melanoma	0.000492	0.000628	CcSEcCtD
Gabapentin—Dermatitis—Bleomycin—melanoma	0.000492	0.000627	CcSEcCtD
Gabapentin—Asthenia—Carmustine—melanoma	0.000489	0.000624	CcSEcCtD
Gabapentin—Hypersensitivity—Temozolomide—melanoma	0.000485	0.000619	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CXCL1—melanoma	0.000482	0.00224	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PLCB4—melanoma	0.000482	0.00224	CbGpPWpGaD
Gabapentin—Syncope—Docetaxel—melanoma	0.000481	0.000614	CcSEcCtD
Gabapentin—Leukopenia—Docetaxel—melanoma	0.000481	0.000613	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PLCB4—melanoma	0.00048	0.00223	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—MAPK1—melanoma	0.000478	0.00221	CbGpPWpGaD
Gabapentin—Palpitations—Docetaxel—melanoma	0.000474	0.000605	CcSEcCtD
Gabapentin—Asthenia—Temozolomide—melanoma	0.000473	0.000603	CcSEcCtD
Gabapentin—Loss of consciousness—Docetaxel—melanoma	0.000472	0.000602	CcSEcCtD
Gabapentin—Cough—Docetaxel—melanoma	0.000468	0.000597	CcSEcCtD
Gabapentin—Diarrhoea—Carmustine—melanoma	0.000466	0.000595	CcSEcCtD
Gabapentin—Pruritus—Temozolomide—melanoma	0.000466	0.000594	CcSEcCtD
Gabapentin—Convulsion—Docetaxel—melanoma	0.000465	0.000593	CcSEcCtD
Gabapentin—Nausea—Bleomycin—melanoma	0.000464	0.000592	CcSEcCtD
Gabapentin—Hypertension—Docetaxel—melanoma	0.000464	0.000591	CcSEcCtD
Gabapentin—Vomiting—Dactinomycin—melanoma	0.000463	0.000591	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—MDM2—melanoma	0.000463	0.00215	CbGpPWpGaD
Gabapentin—Rash—Dactinomycin—melanoma	0.000459	0.000586	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—F2R—melanoma	0.000459	0.00213	CbGpPWpGaD
Gabapentin—Myalgia—Docetaxel—melanoma	0.000457	0.000583	CcSEcCtD
Gabapentin—Chest pain—Docetaxel—melanoma	0.000457	0.000583	CcSEcCtD
Gabapentin—Arthralgia—Docetaxel—melanoma	0.000457	0.000583	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000454	0.000579	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—F2RL1—melanoma	0.000452	0.00209	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC6A11—melanoma	0.000451	0.00209	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIP4K2A—melanoma	0.000451	0.00209	CbGpPWpGaD
Gabapentin—Dizziness—Carmustine—melanoma	0.000451	0.000575	CcSEcCtD
Gabapentin—Diarrhoea—Temozolomide—melanoma	0.000451	0.000575	CcSEcCtD
Gabapentin—Dry mouth—Docetaxel—melanoma	0.000447	0.00057	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—EDNRB—melanoma	0.000445	0.00206	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—VCAN—melanoma	0.000444	0.00206	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYO7A—melanoma	0.000442	0.00205	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DRAP1—melanoma	0.000442	0.00205	CbGpPWpGaD
Gabapentin—Confusional state—Docetaxel—melanoma	0.000442	0.000563	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—CDK4—melanoma	0.000442	0.00205	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTAP—melanoma	0.000439	0.00204	CbGpPWpGaD
Gabapentin—Anaphylactic shock—Docetaxel—melanoma	0.000438	0.000559	CcSEcCtD
Gabapentin—Oedema—Docetaxel—melanoma	0.000438	0.000559	CcSEcCtD
Gabapentin—Dizziness—Temozolomide—melanoma	0.000436	0.000556	CcSEcCtD
Gabapentin—Infection—Docetaxel—melanoma	0.000435	0.000555	CcSEcCtD
Gabapentin—Vomiting—Carmustine—melanoma	0.000433	0.000553	CcSEcCtD
Gabapentin—Nausea—Dactinomycin—melanoma	0.000433	0.000552	CcSEcCtD
Gabapentin—Shock—Docetaxel—melanoma	0.000431	0.00055	CcSEcCtD
Gabapentin—Rash—Carmustine—melanoma	0.00043	0.000548	CcSEcCtD
Gabapentin—Nervous system disorder—Docetaxel—melanoma	0.00043	0.000548	CcSEcCtD
Gabapentin—Dermatitis—Carmustine—melanoma	0.000429	0.000548	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—NOS2—melanoma	0.000429	0.00199	CbGpPWpGaD
Gabapentin—Thrombocytopenia—Docetaxel—melanoma	0.000429	0.000547	CcSEcCtD
Gabapentin—Tachycardia—Docetaxel—melanoma	0.000428	0.000545	CcSEcCtD
Gabapentin—Headache—Carmustine—melanoma	0.000427	0.000545	CcSEcCtD
Gabapentin—Skin disorder—Docetaxel—melanoma	0.000426	0.000543	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GRM3—melanoma	0.000425	0.00197	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—BRAF—melanoma	0.000424	0.00196	CbGpPWpGaD
Gabapentin—Vomiting—Temozolomide—melanoma	0.000419	0.000534	CcSEcCtD
Gabapentin—Anorexia—Docetaxel—melanoma	0.000418	0.000533	CcSEcCtD
Gabapentin—Rash—Temozolomide—melanoma	0.000415	0.00053	CcSEcCtD
Gabapentin—Dermatitis—Temozolomide—melanoma	0.000415	0.000529	CcSEcCtD
Gabapentin—Headache—Temozolomide—melanoma	0.000413	0.000526	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—F2RL1—melanoma	0.00041	0.0019	CbGpPWpGaD
Gabapentin—Hypotension—Docetaxel—melanoma	0.000409	0.000522	CcSEcCtD
Gabapentin—Nausea—Carmustine—melanoma	0.000405	0.000516	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—KISS1—melanoma	0.000403	0.00187	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—melanoma	0.000401	0.00186	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000399	0.000509	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	0.000397	0.00184	CbGpPWpGaD
Gabapentin—Insomnia—Docetaxel—melanoma	0.000396	0.000505	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CXCR4—melanoma	0.000395	0.00183	CbGpPWpGaD
Gabapentin—Paraesthesia—Docetaxel—melanoma	0.000393	0.000502	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—LUM—melanoma	0.000391	0.00181	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PHGDH—melanoma	0.000391	0.00181	CbGpPWpGaD
Gabapentin—Nausea—Temozolomide—melanoma	0.000391	0.000499	CcSEcCtD
Gabapentin—Dyspnoea—Docetaxel—melanoma	0.000391	0.000498	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR1—melanoma	0.00039	0.00181	CbGpPWpGaD
Gabapentin—Somnolence—Docetaxel—melanoma	0.00039	0.000497	CcSEcCtD
Gabapentin—Dyspepsia—Docetaxel—melanoma	0.000386	0.000492	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GRM3—melanoma	0.000386	0.00179	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—MC1R—melanoma	0.000384	0.00178	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HPSE—melanoma	0.000384	0.00178	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—HRAS—melanoma	0.000384	0.00178	CbGpPWpGaD
Gabapentin—Decreased appetite—Docetaxel—melanoma	0.000381	0.000486	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Docetaxel—melanoma	0.000378	0.000482	CcSEcCtD
Gabapentin—Fatigue—Docetaxel—melanoma	0.000378	0.000482	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CUBN—melanoma	0.000377	0.00175	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TAS2R60—melanoma	0.000376	0.00174	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP17A1—melanoma	0.000375	0.00174	CbGpPWpGaD
Gabapentin—Pain—Docetaxel—melanoma	0.000375	0.000478	CcSEcCtD
Gabapentin—Constipation—Docetaxel—melanoma	0.000375	0.000478	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CCR7—melanoma	0.000368	0.00171	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GRM1—melanoma	0.000368	0.00171	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—MAPK1—melanoma	0.000366	0.0017	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KISS1—melanoma	0.000366	0.00169	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SDHD—melanoma	0.000364	0.00169	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CSPG4—melanoma	0.000364	0.00169	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BSG—melanoma	0.000364	0.00169	CbGpPWpGaD
Gabapentin—Feeling abnormal—Docetaxel—melanoma	0.000361	0.00046	CcSEcCtD
Gabapentin—Gastrointestinal pain—Docetaxel—melanoma	0.000358	0.000457	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—MDM2—melanoma	0.000355	0.00164	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCR1—melanoma	0.000354	0.00164	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GNA11—melanoma	0.000354	0.00164	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPAM—melanoma	0.000352	0.00163	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MC1R—melanoma	0.000349	0.00162	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—FASN—melanoma	0.000346	0.00161	CbGpPWpGaD
Gabapentin—Abdominal pain—Docetaxel—melanoma	0.000346	0.000442	CcSEcCtD
Gabapentin—Body temperature increased—Docetaxel—melanoma	0.000346	0.000442	CcSEcCtD
Gabapentin—BCAT1—Metabolism—SLC5A5—melanoma	0.000341	0.00158	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RHOB—melanoma	0.000335	0.00155	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR7—melanoma	0.000334	0.00155	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GRM1—melanoma	0.000334	0.00155	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GNAQ—melanoma	0.000329	0.00153	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CD44—melanoma	0.000329	0.00153	CbGpPWpGaD
Gabapentin—Hypersensitivity—Docetaxel—melanoma	0.000323	0.000412	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—MAPK1—melanoma	0.000317	0.00147	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1B1—melanoma	0.000315	0.00146	CbGpPWpGaD
Gabapentin—Asthenia—Docetaxel—melanoma	0.000314	0.000401	CcSEcCtD
Gabapentin—Pruritus—Docetaxel—melanoma	0.00031	0.000395	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR2—melanoma	0.000305	0.00141	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RHOB—melanoma	0.000304	0.00141	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—EDN1—melanoma	0.000303	0.0014	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RAC2—melanoma	0.0003	0.00139	CbGpPWpGaD
Gabapentin—Diarrhoea—Docetaxel—melanoma	0.0003	0.000382	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PLA2G6—melanoma	0.0003	0.00139	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—HRAS—melanoma	0.000294	0.00136	CbGpPWpGaD
Gabapentin—Dizziness—Docetaxel—melanoma	0.00029	0.000369	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CXCL1—melanoma	0.000285	0.00132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLCB4—melanoma	0.000285	0.00132	CbGpPWpGaD
Gabapentin—Vomiting—Docetaxel—melanoma	0.000279	0.000355	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CXCR2—melanoma	0.000277	0.00128	CbGpPWpGaD
Gabapentin—Rash—Docetaxel—melanoma	0.000276	0.000352	CcSEcCtD
Gabapentin—Dermatitis—Docetaxel—melanoma	0.000276	0.000352	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—melanoma	0.000275	0.00128	CbGpPWpGaD
Gabapentin—Headache—Docetaxel—melanoma	0.000274	0.00035	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—RAC2—melanoma	0.000273	0.00126	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL8—melanoma	0.00027	0.00125	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—VCAN—melanoma	0.000269	0.00125	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—WNT5A—melanoma	0.000268	0.00124	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CUL3—melanoma	0.000268	0.00124	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TRRAP—melanoma	0.000268	0.00124	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKR1B10—melanoma	0.000261	0.00121	CbGpPWpGaD
Gabapentin—Nausea—Docetaxel—melanoma	0.00026	0.000332	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ABCB1—melanoma	0.00026	0.0012	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—F2R—melanoma	0.000259	0.0012	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—melanoma	0.000254	0.00118	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDNRB—melanoma	0.000251	0.00116	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—MAPK1—melanoma	0.000243	0.00112	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2RL1—melanoma	0.000242	0.00112	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PRKCA—melanoma	0.000239	0.00111	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNA11—melanoma	0.000237	0.0011	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GAB2—melanoma	0.000237	0.0011	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ERCC2—melanoma	0.000237	0.0011	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—F2R—melanoma	0.000236	0.00109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDNRB—melanoma	0.000228	0.00106	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRM3—melanoma	0.000228	0.00106	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP17A1—melanoma	0.000227	0.00105	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR4—melanoma	0.000223	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNAQ—melanoma	0.000221	0.00102	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KISS1—melanoma	0.000216	0.001	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNA11—melanoma	0.000215	0.000998	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GAB2—melanoma	0.000215	0.000998	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000215	0.000995	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNA11—melanoma	0.000214	0.000994	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FASN—melanoma	0.00021	0.000973	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SKI—melanoma	0.000209	0.000969	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR1—melanoma	0.000209	0.000969	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC5A5—melanoma	0.000206	0.000957	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MC1R—melanoma	0.000206	0.000955	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT3—melanoma	0.000204	0.000943	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCR4—melanoma	0.000203	0.000939	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNAQ—melanoma	0.0002	0.000928	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNAQ—melanoma	0.000199	0.000924	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CD44—melanoma	0.000199	0.000924	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR7—melanoma	0.000197	0.000915	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRM1—melanoma	0.000197	0.000915	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—HRAS—melanoma	0.000195	0.000902	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SUFU—melanoma	0.000192	0.000892	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1B1—melanoma	0.000191	0.000886	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—melanoma	0.000188	0.00087	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—melanoma	0.000187	0.000868	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT3—melanoma	0.000185	0.000857	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—melanoma	0.000181	0.000838	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BCL2L11—melanoma	0.00018	0.000833	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RHOB—melanoma	0.00018	0.000833	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC6—melanoma	0.000173	0.0008	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—melanoma	0.000172	0.000797	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDN1—melanoma	0.000171	0.000792	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CSF2—melanoma	0.000167	0.000775	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CD—melanoma	0.000165	0.000763	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR2—melanoma	0.000164	0.000758	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—melanoma	0.000164	0.000758	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—melanoma	0.000163	0.000753	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAC2—melanoma	0.000161	0.000746	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCA—melanoma	0.00016	0.000743	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—WNT5A—melanoma	0.000158	0.000734	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFC—melanoma	0.000158	0.000734	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCB1—melanoma	0.000157	0.000729	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDN1—melanoma	0.000155	0.00072	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CSF2—melanoma	0.000152	0.000703	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RAC1—melanoma	0.000149	0.000688	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCA—melanoma	0.000146	0.000674	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PRKCA—melanoma	0.000145	0.000671	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ERCC2—melanoma	0.000144	0.000666	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—melanoma	0.000144	0.000665	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAP2K2—melanoma	0.000142	0.000659	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—melanoma	0.000142	0.000659	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2R—melanoma	0.000139	0.000645	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RAC1—melanoma	0.000135	0.000625	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDNRB—melanoma	0.000135	0.000624	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTK2B—melanoma	0.000131	0.000606	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GAB2—melanoma	0.000127	0.00059	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNA11—melanoma	0.000127	0.00059	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FLT1—melanoma	0.000127	0.000587	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—melanoma	0.000126	0.000582	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—melanoma	0.000124	0.000575	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC2—melanoma	0.00012	0.000554	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FOXO4—melanoma	0.00012	0.000554	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR4—melanoma	0.00012	0.000554	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNAQ—melanoma	0.000118	0.000548	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—melanoma	0.000114	0.000528	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—melanoma	0.000113	0.000526	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SYK—melanoma	0.000111	0.000515	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—melanoma	0.00011	0.000511	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—melanoma	0.00011	0.000508	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ITGAV—melanoma	0.000109	0.000506	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT3—melanoma	0.000109	0.000506	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NGFR—melanoma	0.000109	0.000506	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SOCS1—melanoma	0.000101	0.000469	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAP2K1—melanoma	0.000101	0.000467	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—S100B—melanoma	0.000101	0.000467	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—melanoma	0.0001	0.000464	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—melanoma	9.97e-05	0.000462	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—melanoma	9.85e-05	0.000456	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB4—melanoma	9.64e-05	0.000447	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—melanoma	9.62e-05	0.000446	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN2B—melanoma	9.56e-05	0.000443	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD86—melanoma	9.25e-05	0.000429	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—melanoma	9.24e-05	0.000428	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDN1—melanoma	9.17e-05	0.000425	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CSF2—melanoma	8.97e-05	0.000416	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF1—melanoma	8.97e-05	0.000416	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—melanoma	8.83e-05	0.000409	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—E2F1—melanoma	8.77e-05	0.000407	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—melanoma	8.75e-05	0.000405	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—melanoma	8.73e-05	0.000405	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—melanoma	8.69e-05	0.000403	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFRA—melanoma	8.68e-05	0.000402	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—melanoma	8.61e-05	0.000399	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCA—melanoma	8.6e-05	0.000398	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ITGB3—melanoma	8.6e-05	0.000398	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SPP1—melanoma	8.43e-05	0.000391	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAP2K2—melanoma	8.4e-05	0.000389	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—melanoma	8.39e-05	0.000389	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2—melanoma	8.02e-05	0.000372	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—melanoma	7.99e-05	0.00037	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAC1—melanoma	7.97e-05	0.000369	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—melanoma	7.64e-05	0.000354	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTEN—melanoma	7.51e-05	0.000348	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KDR—melanoma	7.31e-05	0.000339	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—melanoma	7.15e-05	0.000331	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FN1—melanoma	7.04e-05	0.000326	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH1—melanoma	6.89e-05	0.000319	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD80—melanoma	6.75e-05	0.000313	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APC—melanoma	6.73e-05	0.000312	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—melanoma	6.73e-05	0.000312	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KIT—melanoma	6.73e-05	0.000312	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NRAS—melanoma	6.73e-05	0.000312	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGF—melanoma	6.66e-05	0.000308	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK3—melanoma	6.45e-05	0.000299	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BRAF—melanoma	6.33e-05	0.000293	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—melanoma	6.16e-05	0.000286	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK1—melanoma	6.14e-05	0.000284	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—melanoma	6.13e-05	0.000284	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAP2K1—melanoma	5.96e-05	0.000276	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—melanoma	5.92e-05	0.000274	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—melanoma	5.86e-05	0.000272	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—melanoma	5.79e-05	0.000269	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF2—melanoma	5.67e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—melanoma	5.32e-05	0.000247	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MDM2—melanoma	5.3e-05	0.000246	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—melanoma	5.3e-05	0.000246	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB2—melanoma	5.23e-05	0.000242	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—melanoma	5.16e-05	0.000239	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—melanoma	4.96e-05	0.00023	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—melanoma	4.93e-05	0.000228	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1B—melanoma	4.84e-05	0.000224	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—melanoma	4.79e-05	0.000222	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—melanoma	4.75e-05	0.00022	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—melanoma	4.74e-05	0.00022	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—melanoma	4.71e-05	0.000218	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—melanoma	4.62e-05	0.000214	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNB1—melanoma	4.57e-05	0.000212	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—melanoma	4.48e-05	0.000208	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1A—melanoma	4.47e-05	0.000207	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—melanoma	4.46e-05	0.000207	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NFKB1—melanoma	4.44e-05	0.000206	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—melanoma	4.35e-05	0.000202	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—melanoma	4.33e-05	0.000201	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—melanoma	4.03e-05	0.000187	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—melanoma	3.99e-05	0.000185	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRAS—melanoma	3.98e-05	0.000184	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK3—melanoma	3.81e-05	0.000177	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—melanoma	3.7e-05	0.000172	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK1—melanoma	3.62e-05	0.000168	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—melanoma	3.62e-05	0.000168	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—melanoma	3.42e-05	0.000159	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—melanoma	3.15e-05	0.000146	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—melanoma	3.04e-05	0.000141	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—melanoma	2.91e-05	0.000135	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—melanoma	2.78e-05	0.000129	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—melanoma	2.57e-05	0.000119	CbGpPWpGaD
